Orthopedic Surgery Doctors in Odessa, FL Accepting Medicare
5 Orthopedic Surgery doctors found. Showing 1 - 5
 Dr. Farhan Naveed Siddiqi, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 2040 Short Ave Ste 100, Odessa, FL 33556 Phone: 727-372-9922 |
Dr. Victor Hayes, M.D. Orthopaedic Surgery - Orthopaedic Surgery of the Spine Medicare: Accepting Medicare Assignments Practice Location: 2040 Short Ave, Odessa, FL 33556 Phone: 727-372-9922 |
Dr. Hugo Adam Keim, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 16101 Carencia Ln, Odessa, FL 33556 Phone: 813-391-1003 |
Malcolm C Maclaren, DO Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 18133 Patterson Rd, Odessa, FL 33556 Phone: 813-496-1075 Fax: 813-249-7762 |
James Billys, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2040 Short Ave, Odessa, FL 33556 Phone: 727-807-2476 |
News Archive
Jeffrey Modell Foundation urges government to implement SCID screening for all newborns
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, today called upon governors, state public health officials, and legislators, in all states, to implement screening of newborns with Severe Combined Immune Deficiency (SCID).
New study may contribute to ongoing debate on fortification program
Fortifying the U.S. food supply with folic acid was not associated with a decline in certain birth defects that researchers expected to see in California, according to a new study from the Stanford University School of Medicine.
U.S. pivotal clinical trial of Medtronic CoreValve begins
Medtronic, Inc. today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by David H. Adams, M.D., and Samin K. Sharma, M.D., at The Mount Sinai Medical Center in New York City.
Study identifies correlations between BioLight's TeaRx diagnostic parameters and benchmark tests for dry eye syndrome
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced the completion of a U.S. clinical study, conducted by Ora, Inc. Andover, MA, designed to compare widely used benchmark tests for dry eye with its TeaRx diagnostic parameters that test components of tear film.
Researchers develop aflocculating agent to separate and remove textile dyes from the water
The European fashion industry is a huge consumer of fresh water. Estimates point to 600 million cubic meter of fresh water being consumed yearly in Europe by the textile and clothing industry; not a negligible amount.
› Verified 8 days ago
Internal Medicine
Pediatrics
Orthopaedic Surgery
Emergency Medicine
Family Medicine
Radiology